300
Participants
Start Date
December 6, 2024
Primary Completion Date
June 18, 2027
Study Completion Date
June 18, 2027
Placebo
Administered orally as tablets
Rosuvastatin Dose 1
Administered orally as tablets
Rosuvastatin dose 2
Administered orally as tablets
AZD0780
Administered orally as tablets
RECRUITING
Research Site, Baotou
RECRUITING
Research Site, Beijing
NOT_YET_RECRUITING
Research Site, Beijing
NOT_YET_RECRUITING
Research Site, Changchun
NOT_YET_RECRUITING
Research Site, Changchun
NOT_YET_RECRUITING
Research Site, Siping
RECRUITING
Research Site, Shanghai
NOT_YET_RECRUITING
Research Site, Shanghai
NOT_YET_RECRUITING
Research Site, Nanjing
NOT_YET_RECRUITING
Research Site, Bengbu
NOT_YET_RECRUITING
Research Site, Changzhou
NOT_YET_RECRUITING
Research Site, Heze
RECRUITING
Research Site, Tianjin
NOT_YET_RECRUITING
Research Site, Shanghai
NOT_YET_RECRUITING
Research Site, Linhai
NOT_YET_RECRUITING
Research Site, Nanchang
NOT_YET_RECRUITING
Research Site, Pingxiang
NOT_YET_RECRUITING
Research Site, Chongqing
NOT_YET_RECRUITING
Research Site, Changsha
NOT_YET_RECRUITING
Research Site, Changde
NOT_YET_RECRUITING
Research Site, Hengyang
NOT_YET_RECRUITING
Research Site, Wuhan
NOT_YET_RECRUITING
Research Site, Wuhan
NOT_YET_RECRUITING
Research Site, Wuhan
NOT_YET_RECRUITING
Research Site, Luoyang
NOT_YET_RECRUITING
Research Site, Guangzhou
NOT_YET_RECRUITING
Research Site, Guangzhou
NOT_YET_RECRUITING
Research Site, Sanya
RECRUITING
Research Site, Chengdu
NOT_YET_RECRUITING
Research Site, Chengdu
NOT_YET_RECRUITING
Research Site, Deyang
NOT_YET_RECRUITING
Research Site, Nanchong
NOT_YET_RECRUITING
Research Site, Zigong
COMPLETED
Research Site, Xi'an
NOT_YET_RECRUITING
Research Site, Xianyang
NOT_YET_RECRUITING
Research Site, Yinchuan
RECRUITING
Research Site, Hong Kong
NOT_YET_RECRUITING
Research Site, Taiyuan
COMPLETED
Research Site, Hong Kong
NOT_YET_RECRUITING
Research Site, Shatin
Lead Sponsor
AstraZeneca
INDUSTRY